ClinVar Miner

Submissions for variant NM_001166108.2(PALLD):c.1965-12594T>G

gnomAD frequency: 0.00102  dbSNP: rs587780760
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001079639 SCV000166478 benign Pancreatic adenocarcinoma 2024-01-18 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000123173 SCV001154312 benign not provided 2024-01-01 criteria provided, single submitter clinical testing PALLD: BS1, BS2
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV003315814 SCV004016527 likely benign Pancreatic cancer, susceptibility to, 1 2023-07-07 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000123173 SCV001554000 likely benign not provided no assertion criteria provided clinical testing The PALLD p.Leu146Arg variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs587780760) and ClinVar (classified as likley benign by Invitae). The variant was identified in control databases in 141 of 150214 chromosomes at a frequency of 0.0009387 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 64 of 8006 chromosomes (freq: 0.007994), Other in 8 of 4760 chromosomes (freq: 0.001681), African in 19 of 13352 chromosomes (freq: 0.001423), Latino in 19 of 24026 chromosomes (freq: 0.000791), European (non-Finnish) in 30 of 59536 chromosomes (freq: 0.000504) and South Asian in 1 of 20936 chromosomes (freq: 0.000048), but was not observed in the East Asian or European (Finnish) populations. Although the p.Leu146 residue is not conserved in mammals and other organisms, computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein. The variant occurs outside of the splicing consensus sequence and three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.